Top Markets
Coin of the day
Gencurix, Inc. Gencurix, Inc.

Gencurix, Inc.

229000
Rank in Stocks #28100
Gencurix Inc. provides diagnostic solutions in South Korea. Its products... Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Share Price
$1.24
Market Cap
$29.13M
Change (1 day)
3.75%
Change (1 year)
8.90%
Country
KR
Trade Gencurix, Inc. (229000)

Category

P/B ratio for Gencurix, Inc. (229000)
P/B ratio as of 2026 TTM: 0
According to Gencurix, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Gencurix, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors